Tanke Biosciences Corporation (TNBI)
| Market Cap | 576.63K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -98.15K |
| Shares Out | 24.54M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,000 |
| Average Volume | 22,239 |
| Open | 0.0277 |
| Previous Close | 0.0420 |
| Day's Range | 0.0235 - 0.0277 |
| 52-Week Range | 0.0059 - 0.0500 |
| Beta | -0.91 |
| RSI | 42.92 |
| Earnings Date | n/a |
About Accolade
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business. The company monitors and analyses accurate, itemized, and real-time energy data. Its assets are utilized in the monitoring of energy consumption using internet of things (IoT), big data, and artificial intelligence for commercial buildings, such as food retail, quick service, multi-site commercial, education, manufacturing, and hotels. Tanke Biosciences Corporation was incorporated in 1989 and is based in Las Vegas, Neva... [Read more]
Financial Performance
Financial StatementsNews
Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John P. Hopkins has been appointed Executive Chairman of the Company's Boa...